Regular Paper
Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology

https://doi.org/10.1006/scbi.1996.0019Get rights and content

Abstract

The formation of blood vessels through endothelial cell proliferation from extant vasculature (angiogenesis) is a prerequisite for the remodeling, regeneration and repair of tissue. In pathological processes, angiogenesis is a major limiting step in tumor growth and is necessary for tumor formation at metastatic sites. Angiogenesis consists of a sequence of events that include (i) dissolution of the basement membrane, (ii) migration and (iii) proliferation of endothelial cells, (iv) formation of the vascular loop, and (v) formation of a new basement membrane. A variety of factors control and regulate these multiple steps during which the endothelium gives rise to new vessels. Growth factors such as vascular endothelial growth factor or platelet-derived growth factor act directly on endothelial cells and/or activate inflammatory cells (monocytes and T lymphocytes) which in turn synthesize angiogenic factors. SPARC (Secreted Protein Acidic and Rich in Cytsteine), in conjunction with other known angiogenic factors, might act pleiotropically during angiogenesis. Recently, angiostatin, a novel endogenous inhibitor of metastasis, has been reported. This protein, a cleavage product of plasminogen, most likely acts through inhibition of angiogenesis. Current research is focused on the angiogenic and antiangiogenic properties of SPARC and angiostatin and will provide us with a better understanding of how these important factors regulate angiogenesis.

References (0)

Cited by (96)

  • The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy

    2021, International Journal of Biological Macromolecules
    Citation Excerpt :

    Then, the caveolae transport the Gp60-bound HSA, free HSA and HSA-bound drugs across the endothelium, and release them from the basolateral membrane into the extracellular interstitium [10]. SPARC, secreted protein, acidic and rich in cysteine, also termed as osteonectin or basement membrane 40 (BM40), is a secreted glycoprotein that can bind with some kinds of proteins including albumins, and mainly functions in mediating the cell-extracellular environment interactions during the process of morphogenesis, tissue remodeling and angiogenesis [11,12]. Subsequently, HSA-based drugs can bind to SPARC which is highly expressed in a variety of tumors and accumulate in the tumor interstitium.

  • Natural remedies and functional foods as angiogenesis modulators

    2020, Functional Foods in Cancer Prevention and Therapy
  • SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma

    2019, Pathology Research and Practice
    Citation Excerpt :

    However, in this study we did not examined this perspective. It was previously hypothesized that SPARC possibly acts by suppressing the angiogenesis factors, as VEGF and platelet-derived growth factors [30–32]. The role of SPARC in inhibiting the synthesis and secretion of VEGF has also been reported in gliomas [33].

  • Unraveling the Function of Skeletal Muscle as a Secretory Organ: Role of Myokines on Muscle Regulation

    2018, Nutrition and Enhanced Sports Performance: Muscle Building, Endurance, and Strength
View all citing articles on Scopus
View full text